Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic, Phase III, Multi-site, Double-blind, Placebo Controlled, Parallel Arm, Dose Increment Randomised Trial of Regular, Low Dose Extended Release Morphine for Chronic Refractory Breathlessness

NCT02720822 is registered in ClinicalTrials.gov with Flinders University as lead sponsor.

NCT NCT02720822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02720822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic, Phase III, Multi-site, Double-blind, Placebo Controlled, Parallel Arm, Dose Increment Randomised Trial of Regular, Low Dose Extended Release Morphine for Chronic Refractory Breathlessness
Lead sponsor
Flinders University
Phase
Phase 3
Overall status
Completed
Start date
August 8, 2016
Completion date
December 20, 2019
Enrollment
171 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, dyspnea